Development of a Mobile System for Self-management of Schizophrenia (SOS)
Status: | Recruiting |
---|---|
Conditions: | Schizophrenia, Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | September 2014 |
End Date: | August 2016 |
Contact: | Rachel M Brian, MPH |
Email: | Rachel.m.brian@dartmouth.edu |
Phone: | 603-448-0263 |
The goal of the proposed project is to develop and pilot a mobile Self-Management of
Schizophrenia (SOS) system that will administer interventions targeting persistent symptoms
of psychosis, social dysfunction, and poor medication adherence, with the long-term goal of
creating a widely-available system that can be deployed by users as needed, in their own
environments. The hypothesis is that this intervention group will show stronger improvement
in the areas of psychiatric systems, social function, and medication adherence compared to
treatment as usual.
Schizophrenia (SOS) system that will administer interventions targeting persistent symptoms
of psychosis, social dysfunction, and poor medication adherence, with the long-term goal of
creating a widely-available system that can be deployed by users as needed, in their own
environments. The hypothesis is that this intervention group will show stronger improvement
in the areas of psychiatric systems, social function, and medication adherence compared to
treatment as usual.
Inclusion Criteria:
- DSM-IV criteria for schizophrenia or schizoaffective disorder based on the Structured
Clinical Interview for DSM-IV-TR Axis I Disorders 47 (SCID);
- 18 years or older; and
- Prescribed oral antipsychotic medication.
Exclusion Criteria:
- Hearing, vision, or motor impairment that make it impossible to operate a smartphone
or respond to prompts (determined using demonstration smartphone for screening); and
- English reading level below 4th grade (determined using the Wide Range Achievement
Test - 4th Edition).
We found this trial at
1
site
Manchester, New Hampshire 03101
Principal Investigator: Dror Ben-Zeev, PhD
Phone: 603-782-0674
Click here to add this to my saved trials